Intracerebroventricular Administration of Yeast-Produced Human Recombinant Lysosomal β-Hexosaminidase Partially Corrects GM2 Ganglioside Accumulation in the Tay-Sachs Mouse Model
Carlos Javier Alméciga-Díaz(Pontificia Universidad Javeriana), Angela Johana Espejo-Mojica, Volkan Seyrantepe(Izmir Institute of Technology), Andrés Felipe Leal(Alfred I. duPont Hospital for Children), Orhan Kerim İnci(Izmir Institute of Technology)
İYTE (İZMİR YÜKSEK TEKNOLOJİ ENSTİTÜSÜ)
January 1, 2025
Cited by 0
Related Papers
Neu4, a Novel Human Lysosomal Lumen Sialidase, Confers Normal Phenotype to Sialidosis and Galactosialidosis Cells
|Journal of Biological Chemistry|2004|145
Regulation of Phagocytosis in Macrophages by Neuraminidase 1
|Journal of Biological Chemistry|2009|96
Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease
|Experimental Neurology|2017|82
GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease
|Journal of Neuroinflammation|2020|65
Gangliosides as Therapeutic Targets for Neurodegenerative Diseases
|Journal of Lipids|2024|11